Works matching IS 10600280 AND DT 2025 AND VI 59 AND IP 7

Results: 13

Philosophical and Ethical Underpinnings of the Medical Decision-Making Process: A Focus on Patient Values and Preferences.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 666, doi. 10.1177/10600280241289133

By:

Erstad, Brian L.

Publication type:

Article

Efficacy and Safety of Mifepristone and Misoprostol Compared to Misoprostol Alone for the Resolution of Miscarriage and Intrauterine Fetal Death: A Systematic Review and Meta-Analysis.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 636, doi. 10.1177/10600280241289968

By:

Pirrami, Rachael G.;
Reinert, Justin P.

Publication type:

Article

Evaluation of Response to Weight-based Dosing Strategies of Continuous, Fixed-Rate Atracurium Infusions in Critically Ill, Obese Adults With Acute Respiratory Distress Syndrome.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 612, doi. 10.1177/10600280241304406

By:

Patel, Krishn S.;
Sacha, Gretchen L.;
Torbic, Heather;
Bass, Stephanie;
Wang, Lu;
Duggal, Abhijit;
Rudoni, Michael A.

Publication type:

Article

Evaluation of the Incidence of Nocardia Infection in Solid Organ Transplant Recipients on Trimethoprim-Sulfamethoxazole for Opportunistic Infection Prophylaxis.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 604, doi. 10.1177/10600280241302412

By:

Jung, Regina;
Au, Jenny;
Burnell, Jacqueline;
Diamond, Adam;
Shah, Ishani;
Ruggia-Check, Christina

Publication type:

Article

Evaluation of the Efficacy of Piperacillin/Tazobactam in Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Urinary Tract Infections: A Systematic Review of the Literature.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 648, doi. 10.1177/10600280241291604

By:

Sutton, Samantha P.;
Reinert, Justin P.

Publication type:

Article

FDA Approves mRESVIA: Embracing the New Era of RSV Prevention With Advanced mRNA Technology.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 676, doi. 10.1177/10600280241301432

By:

Anfaal, Zainab;
Khan, Zmarak Ahmed;
Aslam, Muhammad Ammar

Publication type:

Article

Reply: FDA Approved mRESVIA: Embracing the New Era of RSV Prevention With Advanced mRNA Technology.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 678, doi. 10.1177/10600280241301430

By:

Wroblewski, Daniel;
Brust-Sisti, Lindsay A.;
Bridgeman, Matthew;
Bridgeman, Mary Barna

Publication type:

Article

A Comparative Study of Fentanyl Versus Hydromorphone in Mechanically Ventilated Intensive Care Unit Patients.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 593, doi. 10.1177/10600280241300648

By:

Beasley, Sarah M.;
Zaihra Rizvi, Tasneem;
Grgurich, Philip E.

Publication type:

Article

A Disproportionality Analysis of Treprostinil Based on FDA Adverse Event Reporting System Database.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 674, doi. 10.1177/10600280241299114

By:

Li, Lingling

Publication type:

Article

Safety of Intermittent Parenteral Midazolam Injection in Hospitalized Patients Admitted to Non-Intensive Care Nursing Units: A Retrospective Matched-Cohort Study.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 620, doi. 10.1177/10600280241299059

By:

Mills, Melanie;
Torr, Haley;
Centanni, Nicolette;
Riker, Richard R.;
Gagnon, David;
Gale, Ashley

Publication type:

Article

Utilizing Theoretical Domains Framework to Determine Barriers to Evidence-Based Recommendations in Non-Valvular Atrial Fibrillation.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 628, doi. 10.1177/10600280241298947

By:

White, Evan;
Kane-Gill, Sandra L.;
Jain, Sandeep;
Medico, Charles;
Ansani, Nicole;
Coons, James C.

Publication type:

Article

Ceftobiprole Medocaril: A New Fifth-Generation Cephalosporin.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 657, doi. 10.1177/10600280241293773

By:

Zimmerman, Justin;
Giuliano, Christopher;
Kale-Pradhan, Pramodini B.

Publication type:

Article

SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Patients With Underlying Risk Factors.

Published in:

Annals of Pharmacotherapy, 2025, v. 59, n. 7, p. 671, doi. 10.1177/10600280241294060

By:

Solinsky, Paul Joseph;
Holstege, Amy;
Burnie, Glen

Publication type:

Article